Will Pharmac become a victim of its own success
2011
Moynihan’s article summarises well the issues surrounding New Zealand’s drug funding authority Pharmac and the Trans-Pacific Partnership trade agreement currently being negotiated with the US.1 Why are US drug companies lobbying against Pharmac when the New Zealand drug market is insignificant in global terms? Pharmac’s success has probably made it a target.
Pharmac operates within a …
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
1
References
2
Citations
NaN
KQI